Mirum Pharmaceuticals (MIRM) Operating Margin (2020 - 2025)
Historic Operating Margin for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q3 2025 value amounting to 1.96%.
- Mirum Pharmaceuticals' Operating Margin rose 159900.0% to 1.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.86%, marking a year-over-year increase of 224000.0%. This contributed to the annual value of 26.0% for FY2024, which is 325600.0% up from last year.
- Per Mirum Pharmaceuticals' latest filing, its Operating Margin stood at 1.96% for Q3 2025, which was up 159900.0% from 3.9% recorded in Q2 2025.
- Over the past 5 years, Mirum Pharmaceuticals' Operating Margin peaked at 1.96% during Q3 2025, and registered a low of 1452.36% during Q4 2021.
- Its 5-year average for Operating Margin is 208.53%, with a median of 58.71% in 2023.
- Per our database at Business Quant, Mirum Pharmaceuticals' Operating Margin skyrocketed by 13299400bps in 2022 and then skyrocketed by 159900bps in 2025.
- Over the past 5 years, Mirum Pharmaceuticals' Operating Margin (Quarter) stood at 1452.36% in 2021, then skyrocketed by 92bps to 122.41% in 2022, then soared by 62bps to 46.85% in 2023, then skyrocketed by 48bps to 24.36% in 2024, then skyrocketed by 108bps to 1.96% in 2025.
- Its Operating Margin stands at 1.96% for Q3 2025, versus 3.9% for Q2 2025 and 13.61% for Q1 2025.